Format
Sort by

Send to

Choose Destination

Search results

Items: 11

1.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

2.

Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.

Krane V, Berger M, Lilienthal J, Winkler K, Schambeck C, Wanner C; German Diabetes and Dialysis Study Investigators.

Clin J Am Soc Nephrol. 2010 May;5(5):874-81. doi: 10.2215/CJN.01170209. Epub 2010 Feb 25.

3.

Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-deficient mice.

Graf C, Zemann B, Rovina P, Urtz N, Schanzer A, Reuschel R, Mechtcheriakova D, Müller M, Fischer E, Reichel C, Huber S, Dawson J, Meingassner JG, Billich A, Niwa S, Badegruber R, Van Veldhoven PP, Kinzel B, Baumruker T, Bornancin F.

J Immunol. 2008 Mar 1;180(5):3457-66.

4.

Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice.

Zemann B, Urtz N, Reuschel R, Mechtcheriakova D, Bornancin F, Badegruber R, Baumruker T, Billich A.

Immunol Lett. 2007 Mar 15;109(1):56-63. Epub 2007 Jan 30.

PMID:
17292973
5.

Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses.

Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, Bornancin F, Cai R, Zemann B, Urtz N, Stingl G, Zlabinger G, Woisetschläger M, Baumruker T, Billich A.

Cell Signal. 2007 Apr;19(4):748-60. Epub 2006 Sep 30.

PMID:
17113265
6.

Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.

Zemann B, Kinzel B, Müller M, Reuschel R, Mechtcheriakova D, Urtz N, Bornancin F, Baumruker T, Billich A.

Blood. 2006 Feb 15;107(4):1454-8. Epub 2005 Oct 13.

7.

What dogs may teach humans about the vertical transmission of allergy predisposition.

Zemann B, Rot A.

Immunology. 2003 Dec;110(4):427-9. No abstract available.

8.

Oral administration of specific antigens to allergy-prone infant dogs induces IL-10 and TGF-beta expression and prevents allergy in adult life.

Zemann B, Schwaerzler C, Griot-Wenk M, Nefzger M, Mayer P, Schneider H, de Weck A, Carballido JM, Liehl E.

J Allergy Clin Immunol. 2003 May;111(5):1069-75.

PMID:
12743572
9.

Importance of early allergen contact for the development of a sustained immunoglobulin E response in a dog model.

Schiessl B, Zemann B, Hodgin-Pickart LA, de Weck AL, Griot-Wenk M, Mayer P, Nefzger M, Schneider H, Liehl E.

Int Arch Allergy Immunol. 2003 Feb;130(2):125-34.

PMID:
12673066
10.

Allergic pulmonary and ocular tissue responses in the absence of serum IgE antibodies (IgE) in an allergic dog model.

Zemann B, Griot-Wenk M, Marti E, Mayer P, Eder C, Nefzger M, Schneider H, de Weck A, Liehl E.

Vet Immunol Immunopathol. 2002 Sep 10;87(3-4):373-8.

PMID:
12072260
11.

A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.

Zemann BI, Moore AS, Rand WM, Mason G, Ruslander DM, Frimberger AE, Wood CA, L'Heureux DA, Gliatto J, Cotter SM.

J Vet Intern Med. 1998 Nov-Dec;12(6):465-70.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk